Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis

BACKGROUND: Atrial fibrillation is the most common arrhythmia of the heart with a prevalence of approximately 2% in the western world. Atrial flutter, another arrhythmia, occurs less often with an incidence of approximately 200,000 new patients per year in the USA. Patients with atrial fibrillation...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Syst Rev
Egile Nagusiak: Sethi, Naqash J., Safi, Sanam, Feinberg, Joshua, Nielsen, Emil E., Gluud, Christian, Jakobsen, Janus C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2017
Gaiak:
Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382469/
https://ncbi.nlm.nih.gov/pubmed/28381269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-017-0470-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak